Vilazodone — Membership Pricing

Other medications in Mental Health

• Vortioxetine
• Zaleplon
• Ziprasidone
• Zuranolone
• Acamprosate
• Alprazolam
• Amphetamine Salts
• Aripiprazole

About Vilazodone

Vilazodone, commonly known by its brand name Viibryd, is an important medication prescribed for Major Depressive Disorder (MDD). Understanding how it works and its typical costs can empower your health journey. At TheDrugClub, we believe managing your medication shouldn't be a financial burden. Learn how our membership can provide significant savings on your vilazodone prescription.

Major Depressive Disorder (MDD) is a complex condition affecting millions, bringing with it persistent feelings of sadness, loss of interest, and significant impacts on daily life. Vilazodone, marketed as Viibryd, is a medication specifically designed to help individuals manage the symptoms of MDD and regain a sense of well-being.

What Does Vilazodone Treat?

Vilazodone is approved by the FDA for the treatment of Major Depressive Disorder in adults. It's not typically used for other conditions, making it a targeted therapy for those struggling with the pervasive symptoms of depression. Your doctor will determine if vilazodone is the right choice for your specific needs, often considering your medical history and response to other treatments.

How Does Vilazodone Work?

Vilazodone belongs to a class of antidepressants known as serotonin partial agonist and reuptake inhibitors, or SPARIs. Its unique mechanism of action involves two main pathways: it helps to block the reuptake of serotonin, an important neurotransmitter in the brain that regulates mood, and it also acts as a partial agonist at specific serotonin receptors. This dual action helps to increase the amount of serotonin available in the brain, which can lead to improved mood, reduced anxiety, and a greater sense of emotional balance over time. As with many antidepressants, it may take several weeks to experience the full therapeutic effects of vilazodone.

Typical Costs of Vilazodone

Being a relatively newer medication, vilazodone can be quite expensive, particularly its brand-name version, Viibryd. Without insurance or discount programs, a month's supply of brand-name vilazodone could range anywhere from $300 to over $500. While a generic version of vilazodone is now available, its cost can still be substantial, varying widely depending on the pharmacy, dosage, and your geographical location. These costs can present a significant barrier for many individuals seeking consistent treatment for MDD.

How TheDrugClub Can Help You Save

At TheDrugClub,

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Vilazodone is approved for (FDA label)

Vilazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies ( 14 )] . Vilazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) in adults ( 1 ).

Source: Read the full FDA label on DailyMed. Label effective date: October 8, 2025.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Boxed warning for Vilazodone (FDA label)

WARNING: SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening and for emergence of suicidal thoughts and behaviors [see Warnings and Precautions ( 5.1 )] . Vilazodone hydrochloride tablets are not approved for use in pediatric patients [see Use in Specific Populations ( 8.4 )]. WARNING: SUICIDAL THOUGHTS AND BEHAVIORS See full prescribing information for complete boxed warning. Antidepressants increase the risk of suicidal thoughts and behaviors in pediatric and young adult patients ( 5.1 ). Closely monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors ( 5.1 ). Vilazodone hydrochloride is not approved for use in pediatric patients ( 8.4 ).

Source: FDA prescribing information (DailyMed). Set ID: f917f30d-f2a7-43eb-836f-53eaa2a31cb0. SPL document ID: 40aa8e57-b9a0-9e45-e063-6294a90ab03e. Label effective date: October 8, 2025. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Dosage forms and strengths for Vilazodone (FDA label)

Vilazodone hydrochloride tablets are available as 10 mg, 20 mg and 40 mg film-coated tablets. 10 mg pink, oval tablet, debossed with “FR 1” on one side 20 mg light orange, oval tablet, debossed with “FR 2” on one side 40 mg light blue, oval tablet, debossed with “FR 3” on one side Tablets: 10 mg, 20 mg, and 40 mg ( 3 )

Source: FDA prescribing information (DailyMed). Set ID: f917f30d-f2a7-43eb-836f-53eaa2a31cb0. SPL document ID: 40aa8e57-b9a0-9e45-e063-6294a90ab03e. Label effective date: October 8, 2025. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Vilazodone (FDA label)

The following adverse reactions are discussed in greater detail in other sections of the labeling: Suicidal Thoughts and Behaviors in Adolescents, and Young Adults [see Warnings and Precautions ( 5.1 )]. Serotonin Syndrome [see Warnings and Precautions ( 5.2 )] Increased Risk of Bleeding [see Warnings and Precautions ( 5.3 )]. Activation of Mania or Hypomania [see Warnings and Precautions ( 5.4 )]. Discontinuation Syndrome [see Warnings and Precautions ( 5.5 )]. Seizures [see Warnings and Precautions ( 5.6 )]. Angle-Closure Glaucoma [see Warnings and Precautions ( 5.7 )] Hyponatremia [see Warnings and Precautions ( 5.8 )] Sexual Dysfunction [see Warnings and Precautions ( 5.9 )]. Most common adverse reactions (incidence ≥ 5% and at least twice the rate of placebo): diarrhea, nausea, vomiting, and insomnia ( 6 ).

Source: FDA prescribing information (DailyMed). Set ID: f917f30d-f2a7-43eb-836f-53eaa2a31cb0. SPL document ID: 40aa8e57-b9a0-9e45-e063-6294a90ab03e. Label effective date: October 8, 2025. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Vilazodone (FDA label)

Concomitant use of monoamine oxidase inhibitors (MAOIs), or use within 14 days of stopping MAOIs ( 4 ). Vilazodone hydrochloride tablets are contraindicated in: Patients taking, or within 14 days of stopping, monoamine oxidase inhibitors (MAOIs), including MAOIs such as linezolid or intravenous methylene blue, because of an increased risk of serotonin syndrome [see Warnings and Precautions ( 5.2 ), Drug Interactions ( 7 )].

Source: FDA prescribing information (DailyMed). Set ID: f917f30d-f2a7-43eb-836f-53eaa2a31cb0. SPL document ID: 40aa8e57-b9a0-9e45-e063-6294a90ab03e. Label effective date: October 8, 2025. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Warnings and precautions for Vilazodone (FDA label)

Serotonin Syndrome: Increased risk when co-administered with other serotonergic agents, but also when taken alone. If it occurs, discontinue vilazodone hydrochloride tablets and serotonergic agents and initiate supportive treatment ( 5.2 ) Increased Risk of Bleeding: Concomitant use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), other antiplatelet drugs, warfarin, and other anticoagulants may increase this risk ( 5.3 ) Activation of Mania/Hypomania: Screen patients for bipolar disorder ( 5.4 ) Seizures: Can occur with treatment.

Source: FDA prescribing information (DailyMed). Set ID: f917f30d-f2a7-43eb-836f-53eaa2a31cb0. SPL document ID: 40aa8e57-b9a0-9e45-e063-6294a90ab03e. Label effective date: October 8, 2025. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Vilazodone (FDA label)

CYP3A4 Inhibitors: The vilazodone hydrochloride dose should not exceed 20 mg once daily when co-administered with strong CYP3A4 inhibitors ( 2.4 , 7 ). CYP3A4 Inducers: Consider increasing vilazodone hydrochloride dosage by 2-fold, up to 80 mg once-daily over 1 to 2 weeks when used concomitantly with strong CYP3A4 inducers for greater than 14 days ( 2.4 , 7 ). 7.1 Drugs Having Clinically Important Interactions With Vilazodone Hydrochloride Tablets Table 4:Clinically Important Drug Interactions with Vilazodone Hydrochloride Concomitant Drug Name or Drug Class Clinical Rationale Clinical Recommendation Monoamine Oxidase Inhibitors (MAOIs) The concomitant use of MAOIs and serotonergic drugs including vilazodone hydrochloride increases the risk of serotonin syndrome.

Source: FDA prescribing information (DailyMed). Set ID: f917f30d-f2a7-43eb-836f-53eaa2a31cb0. SPL document ID: 40aa8e57-b9a0-9e45-e063-6294a90ab03e. Label effective date: October 8, 2025. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.